KR950031085A - 표피증식 질환 치료용 의약 조성물 - Google Patents
표피증식 질환 치료용 의약 조성물 Download PDFInfo
- Publication number
- KR950031085A KR950031085A KR1019950008911A KR19950008911A KR950031085A KR 950031085 A KR950031085 A KR 950031085A KR 1019950008911 A KR1019950008911 A KR 1019950008911A KR 19950008911 A KR19950008911 A KR 19950008911A KR 950031085 A KR950031085 A KR 950031085A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutical composition
- acceptable salt
- pharmacologically acceptable
- treatment
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
아래의 구조식의 안산 디에스테르 화합물 또는 약리학적으로 허용되는 그 염을 함유하는 표피 증식 치료용 의약 조성물.
위의 식에서 R1과 R2는 같거나 상이하며 각각 수소 원자 또는 메틸기를 나타낸다.
본 발명의 조성물은 건선(乾癬), 어린선(魚鱗蘚), 손바닥 또는 발바닥 각피증 및 모공성 홍색 비강진(pityriasis rubra pillaris)등의 표피 증식 질환의 치료제로 유용하다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
보통의 건선이 있는 마우스 모델에서의 시간 경과에 따른 귀의 팽윤율을 나타내는 그래프.
Claims (6)
- 아래의 구조식의 인산 디에스테르 화합물 또는 약리학적으로 허용되는 그 염을 함유하는 표피 증식 치료용 의약 조성물.위의 식에서 R1과 R2는 같거나 상이하며 각각 수소 원자 또는 메틸기를 나타낸다.
- 제1항에 있어서, 국소 적용용의 의약 조성물.
- 제2항에 있어서, 연고제, 액제 또는 겔제인 국소 적용용의 의약 조성물.
- 제3항에 있어서, 상기 화합물 또는 약리학적으로 허용되는 염의 상기 연고제 또는 겔제중에서의 농도가 0.01∼5(w/w)%인 의약 조성물.
- 제3항에 있어서, 상기 화합물 또는 약리학적으로 허용되는 염의 상기 액제중에서의농도가 0.01∼5(w/w)%인 의약 조성물.
- 아래의 구조식의 인산 디에스테르 화합물 또는 약리학적으로 허용되는 그 염을 함유하는 의약 조성물의 유효량을 표피 증식 질환을 가진 환자에게 투여하는 표피 증식 질환 치료방법.위의 식에서 R1과 R2는 같거나 상이하며 각각 수소 원자 또는 메틸기를 나타낸다.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP94-84248 | 1994-04-22 | ||
JP8424894 | 1994-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950031085A true KR950031085A (ko) | 1995-12-18 |
Family
ID=13825166
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950008911A KR950031085A (ko) | 1994-04-22 | 1995-04-15 | 표피증식 질환 치료용 의약 조성물 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0679399B1 (ko) |
KR (1) | KR950031085A (ko) |
AT (1) | ATE156359T1 (ko) |
DE (1) | DE69500511T2 (ko) |
ES (1) | ES2107279T3 (ko) |
TW (1) | TW287103B (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2209690A1 (en) * | 1996-07-31 | 1998-01-31 | Sachiko Matsuura | Therapeutic drug for acne vulgaris |
WO2002026238A1 (en) * | 2000-09-26 | 2002-04-04 | Vital Health Sciences Pty Ltd. | Phosphate derivative supplements |
AUPR549901A0 (en) | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
MXPA04000654A (es) * | 2001-07-27 | 2004-03-19 | Vital Health Sciences Pty Ltd | Terapia dermica usando derivados de fosfato de agente de transferencia de electrones. |
AU2002950713A0 (en) | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
US6645514B1 (en) | 2002-12-19 | 2003-11-11 | Access Business Group International, Llc | Increasing skin cell renewal with water-soluble Vitamin E |
DE602005025979D1 (de) | 2004-03-03 | 2011-03-03 | Vital Health Sciences Pty Ltd | Alkaloid-formulierungen |
EP1893159B1 (en) | 2005-06-17 | 2015-09-30 | Vital Health Sciences Pty Ltd. | A carrier comprising one or more di- and/or monophosphate derivatives of electron transfer agents |
KR20080085839A (ko) * | 2005-12-23 | 2008-09-24 | 바이탈 헬스 사이언시즈 피티와이 리미티드 | 사이토킨 조절 특성을 가진 화합물 |
WO2011094814A1 (en) | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
MX2012011355A (es) | 2010-03-30 | 2012-11-30 | Phosphagenics Ltd | Parche de suministro transdermico. |
US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
AU2016367708B2 (en) | 2015-12-09 | 2022-07-14 | Phosphagenics Limited | Pharmaceutical formulation |
KR102647670B1 (ko) | 2016-12-21 | 2024-03-15 | 아베초 바이오테크놀로지 리미티드 | 방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5659710A (en) * | 1979-10-22 | 1981-05-23 | Eisai Co Ltd | Preventive and remedy for psoriasis |
JPS62145019A (ja) * | 1985-12-19 | 1987-06-29 | Senjiyu Seiyaku Kk | 抗炎症剤 |
US5122536A (en) * | 1989-10-12 | 1992-06-16 | Perricone Nicholas V | Method for the topical treatment of psoriasis |
-
1995
- 1995-04-10 TW TW084103423A patent/TW287103B/zh active
- 1995-04-13 DE DE69500511T patent/DE69500511T2/de not_active Expired - Fee Related
- 1995-04-13 AT AT95302497T patent/ATE156359T1/de not_active IP Right Cessation
- 1995-04-13 ES ES95302497T patent/ES2107279T3/es not_active Expired - Lifetime
- 1995-04-13 EP EP95302497A patent/EP0679399B1/en not_active Expired - Lifetime
- 1995-04-15 KR KR1019950008911A patent/KR950031085A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ES2107279T3 (es) | 1997-11-16 |
DE69500511D1 (de) | 1997-09-11 |
EP0679399B1 (en) | 1997-08-06 |
EP0679399A1 (en) | 1995-11-02 |
TW287103B (ko) | 1996-10-01 |
DE69500511T2 (de) | 1998-01-02 |
ATE156359T1 (de) | 1997-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950031085A (ko) | 표피증식 질환 치료용 의약 조성물 | |
IL127965A0 (en) | Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same | |
DE69625906D1 (de) | Dinukleotide zur verwendung in der behandlung von lungenkrankheiten | |
DE69713526D1 (de) | Lösliche prodrugs von paclitaxel | |
ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
BE904421A (fr) | Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique. | |
ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
BR0110420A (pt) | Agonistas muscarìnicos | |
ATE121939T1 (de) | Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion. | |
NO981528L (no) | Substituerte imidazoler med antikreft- og cytokininhibitoraktivitet | |
BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
DE69433818D1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
ATE177640T1 (de) | Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung | |
ATE62414T1 (de) | Mittel zur behandlung von herzerkrankungen. | |
ATE16191T1 (de) | Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten. | |
DE69535081D1 (de) | Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis | |
DE4394931T1 (de) | Verwendung von Norastemizol zur Behandlung von allergischen Erkrankungen | |
DE59600683D1 (de) | Verwendung von Trospiumchlorid zur Herstellung eines Arzneimittels zur Behandlung von Blasenkrankheiten | |
DE60218843D1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
KR950016760A (ko) | 치질 치료제 | |
DE69707372D1 (de) | Verwendung eines Phosphorsäurediesters zur Herstellung eines Arzneimittels zur Behandlung von Akne | |
ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
KR950031084A (ko) | 국소용 진양(鎭洋) 조성물 | |
RS49596B (sr) | Primena farmaceutske kompozicije za dobijanje leka u obliku gela |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |